source
- Lonza appoints Samanta Cimitan as chief commercial officer as WuXi Biologics posts revenue surgeLonza said it will create a new chief commercial officer position and has selected Samanta Cimitan, the current chief executive of Celonic, to take the role on Jan. 1 next year. Cimitan will be re…
- Proposed Biotech Investment National Security Act may protect US firms but contains loophole aiding Chinese competitionA bipartisan bill called the Biotech Investment National Security Act (BINSA) has been introduced in Congress to expand federal oversight of biotechnology activities, from drug development to biolo…